Amedisys Past Earnings Performance
Past criteria checks 0/6
Amedisys's earnings have been declining at an average annual rate of -5%, while the Healthcare industry saw earnings growing at 11.6% annually. Revenues have been growing at an average rate of 6% per year. Amedisys's return on equity is 0.1%, and it has net margins of 0.1%.
Key information
-5.0%
Earnings growth rate
-5.1%
EPS growth rate
Healthcare Industry Growth | 11.6% |
Revenue growth rate | 6.0% |
Return on equity | 0.1% |
Net Margin | 0.1% |
Last Earnings Update | 30 Sep 2023 |
Recent past performance updates
No updates
Recent updates
No updates
Revenue & Expenses Breakdown
How Amedisys makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 23 | 2,228 | 3 | 774 | 0 |
30 Jun 23 | 2,229 | 2 | 789 | 0 |
31 Mar 23 | 2,234 | 112 | 764 | 0 |
31 Dec 22 | 2,223 | 119 | 754 | 0 |
30 Sep 22 | 2,220 | 121 | 1,095 | 0 |
30 Jun 22 | 2,216 | 140 | 966 | 0 |
31 Mar 22 | 2,222 | 191 | 839 | 0 |
31 Dec 21 | 2,214 | 209 | 711 | 0 |
30 Sep 21 | 2,206 | 220 | 234 | 0 |
30 Jun 21 | 2,196 | 247 | 231 | 0 |
31 Mar 21 | 2,117 | 202 | 220 | 0 |
31 Dec 20 | 2,072 | 184 | 668 | 0 |
30 Sep 20 | 2,021 | 166 | 216 | 0 |
30 Jun 20 | 1,972 | 128 | 214 | 0 |
31 Mar 20 | 1,980 | 127 | 219 | 0 |
31 Dec 19 | 1,956 | 127 | 213 | 0 |
30 Sep 19 | 1,889 | 127 | 207 | 0 |
30 Jun 19 | 1,812 | 124 | 197 | 0 |
31 Mar 19 | 1,731 | 123 | 189 | 0 |
31 Dec 18 | 1,663 | 119 | 185 | 0 |
30 Sep 18 | 1,626 | 88 | 181 | 0 |
30 Jun 18 | 1,583 | 71 | 178 | 0 |
31 Mar 18 | 1,546 | 42 | 178 | 0 |
31 Dec 17 | 1,511 | 30 | 177 | 0 |
30 Sep 17 | 1,474 | 43 | 181 | 0 |
30 Jun 17 | 1,456 | 40 | 187 | 0 |
31 Mar 17 | 1,438 | 46 | 190 | 0 |
31 Dec 16 | 1,419 | 37 | 196 | 0 |
30 Sep 16 | 1,391 | 41 | 198 | 0 |
30 Jun 16 | 1,358 | 38 | 193 | 0 |
31 Mar 16 | 1,313 | 38 | 188 | 0 |
31 Dec 15 | 1,266 | -3 | 173 | 0 |
30 Sep 15 | 1,230 | -7 | 158 | 0 |
30 Jun 15 | 1,204 | -7 | 149 | 0 |
31 Mar 15 | 1,193 | -10 | 142 | 0 |
31 Dec 14 | 1,188 | 13 | 147 | 0 |
30 Sep 14 | 1,191 | -4 | 153 | 0 |
30 Jun 14 | 1,192 | -103 | 161 | 0 |
31 Mar 14 | 1,203 | -109 | 167 | 0 |
31 Dec 13 | 1,233 | -93 | 170 | 0 |
30 Sep 13 | 1,278 | -191 | 176 | 0 |
30 Jun 13 | 1,340 | -90 | 182 | 0 |
31 Mar 13 | 1,394 | -84 | 188 | 0 |
Quality Earnings: A2ME34 has a large one-off loss of $131.2M impacting its last 12 months of financial results to 30th September, 2023.
Growing Profit Margin: A2ME34's current net profit margins (0.1%) are lower than last year (5.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A2ME34's earnings have declined by 5% per year over the past 5 years.
Accelerating Growth: A2ME34's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: A2ME34 had negative earnings growth (-97.8%) over the past year, making it difficult to compare to the Healthcare industry average (-3%).
Return on Equity
High ROE: A2ME34's Return on Equity (0.1%) is considered low.